COVID-19 At-Home Test Coverage

Updated 1/14/2022

Starting January 15, 2022, Health New England will cover the costs of FDA-authorized, rapid, at-home COVID tests for commercial and Medicare Advantage members for the duration of the public health emergency.

  • We will cover up to eight (8) over-the-counter at-home individual tests per month. The tests are without any cost-share and without any need for prior clinical assessment.
  • As a reminder, members are covered with no limits for FDA-authorized COVID diagnostic tests, including at-home tests, if ordered or administered by a health care provider following an individualized clinical assessment.
  • We are working to implement processes to provide direct coverage at preferred pharmacies to make it as easy as possible for our members and will have more information in the coming days.
  • In the interim, we ask members to save copies of receipts for any FDA-approved, at-home COVID-19 tests purchased on or after January 15. Members can submit for reimbursement by printing and mailing the form located here.

FDA- Approved At-Home COVID-19 Tests:

  • BINAXNOW COVID-19 AG CARD HOME TEST
  • ELLUME COVID-19 HOME TEST
  • ELLUME COVID-19 HOME TEST
  • FLOWFLEX COVID-19 AG HOMETEST
  • FLOWFLEX COVID-19 ANTIGEN HOME TEST
  • INTELISWAB COVID-19 RAPID TEST
  • ON/GO COVID-19 ANTIGEN SELF-TEST
  • QUICKVUE AT-HOME COVID-19 TEST
  • QUICKVUE AT-HOME COVID-19 TEST


HNE